BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zielińska A, Szalata M, Gorczyński A, Karczewski J, Eder P, Severino P, Cabeda JM, Souto EB, Słomski R. Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications. Cancers (Basel) 2021;13:1896. [PMID: 33920840 DOI: 10.3390/cancers13081896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kouhdareh J, Keypour H, Alavinia S, Maryamabadi A. Pd(II)-immobilized on a novel covalent imine framework (COF-BASU1) as an efficient catalyst for asymmetric Suzuki coupling. Journal of Molecular Structure 2023;1273:134286. [DOI: 10.1016/j.molstruc.2022.134286] [Reference Citation Analysis]
2 Tudose M, Culita DC, Baratoiu-Carpen RD, Mitran RA, Kuncser A, Romanitan C, Popescu RC, Savu DI. Novel Antitumor Agents Based on Fluorescent Benzofurazan Derivatives and Mesoporous Silica. Int J Mol Sci 2022;23. [PMID: 36555305 DOI: 10.3390/ijms232415663] [Reference Citation Analysis]
3 Lu F, Zhu Y, Zhang G, Liu Z. Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy. Front Pharmacol 2022;13:944147. [DOI: 10.3389/fphar.2022.944147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Souto EB, da Ana R, Vieira V, Fangueiro JF, Dias-ferreira J, Cano A, Zielińska A, Silva AM, Staszewski R, Karczewski J. Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments. Neoplasia 2022;30:100810. [DOI: 10.1016/j.neo.2022.100810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Łasińska I, Zielińska A, Mackiewicz J, Souto EB. Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles. Cancers 2022;14:2778. [DOI: 10.3390/cancers14112778] [Reference Citation Analysis]
6 Eras A, Castillo D, Suárez M, Vispo NS, Albericio F, Rodriguez H. Chemical Conjugation in Drug Delivery Systems. Front Chem 2022;10:889083. [DOI: 10.3389/fchem.2022.889083] [Reference Citation Analysis]
7 Negrea G, Rauca VF, Meszaros MS, Patras L, Luput L, Licarete E, Toma VA, Porfire A, Muntean D, Sesarman A, Banciu M. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis. Front Pharmacol 2022;13:870347. [PMID: 35450036 DOI: 10.3389/fphar.2022.870347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Argenziano M, Arpicco S, Brusa P, Cavalli R, Chirio D, Dosio F, Gallarate M, Peira E, Stella B, Ugazio E. Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research. Pharmaceutics 2021;13:1538. [PMID: 34683830 DOI: 10.3390/pharmaceutics13101538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Clogston JD. The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand. Adv Drug Deliv Rev 2021;176:113897. [PMID: 34314786 DOI: 10.1016/j.addr.2021.113897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Liu S, Deng S, Li X, Cheng D. Size- and Surface- Dual Engineered Small Polyplexes for Efficiently Targeting Delivery of siRNA. Molecules 2021;26:3238. [PMID: 34072265 DOI: 10.3390/molecules26113238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]